SCHEMBL694354

SCHEMBL694354

CC(=O)CC(Cl)N1CCN(S(=O)(=O)c2cc([N+](=O)[O-])ccc2Sc2cc(C)ccc2C)CC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.45
LMNA P02545 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
MAPT P10636 3/20 0.45
HTT P42858 2/20 0.45
POLB P06746 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
EPHX2 P34913 2/20 0.40
ALDH1A1 P00352 6/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HPGD P15428 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.39
XBP1 P17861 1/20 0.38
RECQL P46063 1/20 0.38
TBXA2R P21731 1/20 0.38
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694143 0.86 L3MBTL1 (0.47) L3MBTL1LMNASMN1; SMN2MAPTHTT
SCHEMBL694451 0.85 L3MBTL1 (0.53) L3MBTL1LMNASMN1; SMN2MAPTHTT
SCHEMBL3105996 0.84 L3MBTL1 (0.52) L3MBTL1LMNASMN1; SMN2MAPTHTT
SCHEMBL3113383 0.83 NPC1 (0.53) L3MBTL1LMNASMN1; SMN2MAPTHTT
SCHEMBL694598 0.82 L3MBTL1 (0.56) L3MBTL1LMNASMN1; SMN2MAPTHTT
SCHEMBL3109122 0.81 L3MBTL1 (0.53) L3MBTL1LMNASMN1; SMN2MAPTHTT
SCHEMBL697867 0.81 ALDH1A1 (0.55) L3MBTL1LMNASMN1; SMN2MAPTHTT
SCHEMBL12693458 0.80 ALDH1A1 (0.55) L3MBTL1LMNASMN1; SMN2MAPTHTT
SCHEMBL3113893 0.80 L3MBTL1 (0.45) L3MBTL1LMNASMN1; SMN2MAPTHTT
SCHEMBL693874 0.79 L3MBTL1 (0.55) L3MBTL1LMNASMN1; SMN2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421838-A2 ARYLSULFONAMIDE CCR3 ANTAGONISTS Axikin Pharmaceuticals, Inc. (US) 2012-02-29 EP disclosed
WO-2010123960-A2 ARYLSULFONAMIDE CCR3 ANTAGONISTS AXIKIN PHARMACEUTICALS, INC. (US) 2010-10-28 WO disclosed